Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,927 | 18,844 | 16,507 | 16,765 | 33,629 |
| Marketable Securities | 19,472 | 83,510 | 46,365 | 55,213 | 48,641 |
| Receivables | 15,266 | 8,595 | 13,433 | 11,421 | 5,245 |
| Inventories | 13,312 | 17,878 | 23,065 | 15,634 | 10,955 |
| TOTAL | $81,046 | $131,659 | $101,619 | $109,011 | $110,541 |
| Non-Current Assets | |||||
| PPE Net | 30,070 | 34,073 | 37,920 | 14,560 | 8,548 |
| Other Non-Current Assets | 36,869 | 4,543 | 4,545 | 14,313 | 12,018 |
| TOTAL | $66,939 | $38,616 | $42,465 | $28,873 | $20,566 |
| Total Assets | $147,985 | $170,275 | $144,084 | $137,884 | $131,107 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,368 | 6,736 | 9,093 | 8,359 | 4,749 |
| Accrued Expenses | 13,242 | 12,823 | 12,618 | 16,604 | 15,551 |
| Other current liabilities | 225 | 788 | 605 | 1,681 | 241 |
| TOTAL | $49,153 | $26,884 | $28,635 | $33,774 | $38,178 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 14,659 | 13,635 | 16,106 | 14,948 |
| Deferred Revenues | 7,610 | 6,537 | 6,319 | 7,130 | 17,637 |
| Other Non-Current Liabilities | 41,964 | 16 | 14,636 | 2,020 | 1,986 |
| TOTAL | $43,915 | $29,330 | $29,346 | $19,442 | $19,389 |
| Total Liabilities | $93,068 | $56,214 | $57,981 | $53,216 | $57,567 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 153,136 | 150,960 | 130,694 | 92,725 | 85,731 |
| Common Shares | 153 | 150 | 116 | 93 | 80 |
| Retained earnings | -1,066,240 | -982,106 | -879,733 | -787,544 | -713,169 |
| Other shareholders' equity | 5 | -36 | -32 | 5 | -7 |
| TOTAL | $54,917 | $114,061 | $86,103 | $84,668 | $73,540 |
| Total Liabilities And Equity | $147,985 | $170,275 | $144,084 | $137,884 | $131,107 |